These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38470007)

  • 1. Link among apolipoprotein E E4, gait, and cognition in neurodegenerative diseases: ONDRI study.
    Sakurai R; Pieruccini-Faria F; Cornish B; Fraser J; Binns MA; Beaton D; Dilliott AA; Kwan D; Ramirez J; Tan B; Scott CJM; Sunderland KM; Tartaglia C; Finger E; Zinman L; Freedman M; McLaughlin PM; Swartz RH; Symons S; Lang AE; Bartha R; Black SE; Masellis M; Hegele RA; McIlroy W; ; Montero-Odasso M
    Alzheimers Dement; 2024 Apr; 20(4):2968-2979. PubMed ID: 38470007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Brain Amyloid-β With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E ε4 Genotype.
    Nadkarni NK; Perera S; Snitz BE; Mathis CA; Price J; Williamson JD; DeKosky ST; Klunk WE; Lopez OL
    JAMA Neurol; 2017 Jan; 74(1):82-90. PubMed ID: 27842173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a significant interaction effect between apolipoprotein E rs405509 T/T and ε4 genotypes on cognitive impairment and gray matter volume?
    Ma C; Zhang Y; Li X; Zhang J; Chen K; Liang Y; Chen Y; Liu Z; Zhang Z
    Eur J Neurol; 2016 Sep; 23(9):1415-25. PubMed ID: 27259692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of APOE ε4 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study.
    Gharbi-Meliani A; Dugravot A; Sabia S; Regy M; Fayosse A; Schnitzler A; Kivimäki M; Singh-Manoux A; Dumurgier J
    Alzheimers Res Ther; 2021 Jan; 13(1):5. PubMed ID: 33397450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the synergistic effects of hormone replacement therapy, apolipoprotein E and age on brain health in the UK Biobank.
    Ambikairajah A; Khondoker M; Morris E; de Lange AG; Saleh RNM; Minihane AM; Hornberger M
    Hum Brain Mapp; 2024 Feb; 45(2):e26612. PubMed ID: 38339898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotypic Effects of the TOMM40'523 Variant and APOE on Longitudinal Cognitive Change over 4 Years: The TOMMORROW Study.
    Zou H; Luo S; Liu H; Lutz MW; Bennett DA; Plassman BL; Welsh-Bohmer KA
    J Prev Alzheimers Dis; 2023; 10(4):886-894. PubMed ID: 37874111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Variation in the Ontario Neurodegenerative Disease Research Initiative.
    Dilliott AA; Evans EC; Farhan SMK; Ghani M; Sato C; Zhang M; McIntyre AD; Cao H; Racacho L; Robinson JF; Strong MJ; Masellis M; Bulman DE; Rogaeva E; Black SE; Finger E; Frank A; Freedman M; Hassan A; Lang A; Shoesmith CL; Swartz RH; Tang-Wai D; Tartaglia MC; Turnbull J; Zinman L; ; Hegele RA
    Can J Neurol Sci; 2019 Sep; 46(5):491-498. PubMed ID: 31217043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele.
    Caselli RJ; Reiman EM; Osborne D; Hentz JG; Baxter LC; Hernandez JL; Alexander GG
    Neurology; 2004 Jun; 62(11):1990-5. PubMed ID: 15184602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White Matter Hyperintensities and Apolipoprotein E Affect the Association Between Mean Arterial Pressure and Objective and Subjective Cognitive Functioning in Older Adults.
    Jung Y; Viviano RP; van Rooden S; van der Grond J; Rombouts SARB; Damoiseaux JS
    J Alzheimers Dis; 2021; 84(3):1337-1350. PubMed ID: 34657884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between apolipoprotein E genotype and hypertension on cognitive function in older women in the Nurses' Health Study.
    Kim IY; Grodstein F; Kraft P; Curhan GC; Hughes KC; Huang H; Kang JH; Hunter DJ
    PLoS One; 2019; 14(11):e0224975. PubMed ID: 31697783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOE genotype modulates proton magnetic resonance spectroscopy metabolites in the aging brain.
    Gomar JJ; Gordon ML; Dickinson D; Kingsley PB; Uluğ AM; Keehlisen L; Huet S; Buthorn JJ; Koppel J; Christen E; Conejero-Goldberg C; Davies P; Goldberg TE
    Biol Psychiatry; 2014 May; 75(9):686-92. PubMed ID: 23831342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and resting-state MRI detects regional brain differences in young and mid-age healthy APOE-e4 carriers compared with non-APOE-e4 carriers.
    Dowell NG; Evans SL; Tofts PS; King SL; Tabet N; Rusted JM
    NMR Biomed; 2016 May; 29(5):614-24. PubMed ID: 26929040
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Haller S; Montandon ML; Rodriguez C; Ackermann M; Herrmann FR; Giannakopoulos P
    AJNR Am J Neuroradiol; 2017 Jul; 38(7):1335-1342. PubMed ID: 28495939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Apolipoprotein E4 Polymorphism on the Gray Matter Volume and the White Matter Integrity in Subjective Memory Impairment without White Matter Hyperintensities: Voxel-Based Morphometry and Tract-Based Spatial Statistics Study under 3-Tesla MRI.
    Lee YM; Ha JK; Park JM; Lee BD; Moon E; Chung YI; Kim JH; Kim HJ; Mun CW; Kim TH; Kim YH
    J Neuroimaging; 2016; 26(1):144-9. PubMed ID: 25678236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AD and non-AD mediators of the pathway between the APOE genotype and cognition.
    Nichols E; Brickman AM; Casaletto KB; Dams-O'Connor K; George KM; Kumar RG; Palta P; Rabin JS; Satizabal CL; Schneider J; Pa J; La Joie R
    Alzheimers Dement; 2023 Jun; 19(6):2508-2519. PubMed ID: 36516004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOE e4 genotype and cigarette smoking in adults with normal cognition and mild cognitive impairment: a retrospective baseline analysis of a national dataset.
    Kalapatapu RK; Delucchi KL
    Am J Drug Alcohol Abuse; 2013 Jul; 39(4):219-26. PubMed ID: 23808899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Red Blood Cell Omega-3 Fatty Acids With MRI Markers and Cognitive Function in Midlife: The Framingham Heart Study.
    Satizabal CL; Himali JJ; Beiser AS; Ramachandran V; Melo van Lent D; Himali D; Aparicio HJ; Maillard P; DeCarli CS; Harris WS; Seshadri S
    Neurology; 2022 Dec; 99(23):e2572-e2582. PubMed ID: 36198518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of apolipoprotein E variation with cognitive impairment across multiple neurodegenerative diagnoses.
    Dilliott AA; Sunderland KM; McLaughlin PM; Roberts AC; Evans EC; Abrahao A; Binns MA; Black SE; Borrie M; Casaubon LK; Dowlatshahi D; Finger E; Fischer CE; Frank A; Freedman M; Grimes D; Hassan A; Jog M; Kumar S; Kwan D; Lang AE; Mandzia J; Marras C; Masellis M; McIntyre AD; Pasternak S; Pollock BG; Rajji TK; Robinson JF; Rogaeva E; Sahlas DJ; Saposnik G; Sato C; Seitz D; Shoesmith C; Steeves T; Strother SC; Swartz RH; Tan B; Tang-Wai D; Tartaglia MC; Troyer AK; Turnbull J; Zinman L; ; Hegele RA
    Neurobiol Aging; 2021 Sep; 105():378.e1-378.e9. PubMed ID: 34039480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiety correlates with cortical surface area in subjective cognitive decline: APOE ε4 carriers versus APOE ε4 non-carriers.
    Sun Y; Wang X; Wang Y; Dong H; Lu J; Scheininger T; Ewers M; Jessen F; Zuo XN; Han Y
    Alzheimers Res Ther; 2019 Jun; 11(1):50. PubMed ID: 31159873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid olfactory decline during aging predicts dementia and GMV loss in AD brain regions.
    Pacyna RR; Han SD; Wroblewski KE; McClintock MK; Pinto JM
    Alzheimers Dement; 2023 Apr; 19(4):1479-1490. PubMed ID: 35899859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.